EASL 2018 Conference Review - reviewed by Professor Golo Ahlenstiel

In this Review:

Ursodeoxycholic acid in primary biliary cholangitis
Pharmacokinetics/pharmacodynamics of seladelpar
Mortality and morbidity in primary sclerosing cholangitis
NAFLD, steatohepatitis, cirrhosis and hepatocellular carcinoma
Selective thyroid hormone receptor-β agonist for NASH
Cenicriviroc treatment for adults with NASH
Hepatocellular carcinoma in HCV-cirrhotic patients
Hepatocellular carcinoma after DAAs for HCV
Multidrug-resistant bacterial infections in cirrhosis
Bacterial peritonitis prophylaxis in cirrhosis
Diet, gut microbiota and hospitalisation risk in cirrhosis
Spontaneous clearance of HCV RNA after relapse following DAA therapy
Seroclearance in chronic HBV patients

Please login below to download this issue (PDF)

Subscribe